Records containing: Severe Aplastic Anemia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-01-26HLA-Haploidentical Related Marrow Grafts for the Treatment of Primary Immunodeficiencies and Other Nonmalignant Disorders Using Conditioning With Low-Dose Cyclophosphamide, TBI and Fludarabine and Postgrafting Cyclophosphamide
-
CLINICAL_TRIALS study record update · 2020-06-05Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2019-12-26Abatacept for Post-Transplant Immune Suppression in Children and Adolescents Receiving Allogeneic Hematopoietic Stem Cell Transplants for Non-Malignant Diseases
-
CLINICAL_TRIALS study record update · 2019-10-25Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2018-11-27Outcome of Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin (ATG ) Conditioning Regimens in Severe Aplastic Anemia Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2018-11-02New York Blood Center National Cord Blood Program
-
CLINICAL_TRIALS study record update · 2017-10-19Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2017-08-11A Research on Haploidentical Transplantation in Severe Aplastic Anemia Using Reduced-intensity Fludarabine-based Conditioning
-
CLINICAL_TRIALS study record update · 2016-10-13A Phase II Trial of Myeloablative Conditioning and Transplantation of HLA-matched, Partially HLA-mismatched, HLA-haploidentical or Matched Unrelated (MUD) Bone Marrow for Patients With Refractory Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2016-03-02A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2015-11-11Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2015-04-03A Multicenter, Randomized, Controlled Study of the Efficacy and Safety of the Combination of Adipose Tissue-derived Hematopoietic Stem Cells (AD-HSCs) and ATG in the Treatment of Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2015-03-09Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation for Children With Non-Malignant Diseases Who Have Been Multiply Transfused: a Pilot Study
-
CLINICAL_TRIALS study record update · 2014-09-25PhaseⅡTrial of Co-transplantation With Bone Marrow Derived Mesenchymal Stem Cells From Related Donors in Alternative Donor Transplantation of Severe Aplastic Anemia.
-
CLINICAL_TRIALS study record update · 2014-08-20Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2013-12-03Different Doses of Anti-thymocyte Globin With 2.5 or 3.75mg/kg to Treat Child Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2013-11-11Allogeneic Mixed Chimerism Stem Cell Transplantation Utilizing In Vivo and In Vitro Campath for Hemoglobinopathies and Bone Marrow Failure Syndromes
-
CLINICAL_TRIALS study record update · 2012-08-09Cd45 (Yth-24 and Yth 54) and Cd52 (Campath-1H) Monoclonal Antibody Conditioning Regimen for Allogeneic Donor Stem Cell Transplantation of Patients With Fanconi Anemia
-
CLINICAL_TRIALS study record update · 2012-03-27Reduced-Intensity Preparative Regimen for Allogeneic Stem Cell Transplantation in Patients With Severe Aplastic Anemia
-
CLINICAL_TRIALS study record update · 2009-01-26Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing Matched Unrelated Donor Stem Cell Transplantation